During the past decade, Center for Psychiatry and Behavioral Medicine, Inc. conducted 42 clinical trials. In the 10-year time frame, 42 clinical trials started and 40 clinical trials were completed, i.e. on average, 95.2% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 18 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Center for Psychiatry and Behavioral Medicine, Inc." #1 sponsor was "Shire" with 23 trials, followed by "Sunovion" with 9 trials sponsored, "Rhodes Pharmaceuticals, L.P." with 6 trials sponsored, "Akili Interactive Labs, Inc." with 5 trials sponsored and "Otsuka Pharmaceutical Development & Commercialization, Inc." with 5 trials sponsored. Other sponsors include 27 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Center for Psychiatry and Behavioral Medicine, Inc." #1 collaborator was "Purdue Pharma LP" with 3 trials as a collaborator, "Otsuka America Pharmaceutical" with 2 trials as a collaborator, "Autism Speaks" with 1 trials as a collaborator, "Center for Psychiatry And Behavioral Medicine Inc." with 1 trials as a collaborator and "Food and Drug Administration (FDA)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Center for Psychiatry and Behavioral Medicine, Inc." are "Attention Deficit Hyperactivity Disorder" (17 trials), "ADHD" (14 trials), "Attention Deficit Hyperactivity Disorder (ADHD)" (9 trials), "Attention Deficit Disorder With Hyperactivity" (7 trials) and "Attention-Deficit/Hyperactivity Disorder" (5 trials). Many other conditions were trialed in "Center for Psychiatry and Behavioral Medicine, Inc." in a lesser frequency.

Most popular intervention types in "Center for Psychiatry and Behavioral Medicine, Inc." are "Drug" (73 trials), "Other" (9 trials) and "Device" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (39 trials), "SPD489" (4 trials), "AKL-T01" (3 trials), "Aripiprazole" (3 trials) and "Dasotraline" (3 trials). Other intervention names were less common.

The vast majority of trials in "Center for Psychiatry and Behavioral Medicine, Inc." are 79 trials for "All" genders.

Currently, there are NaN active trials in "Center for Psychiatry and Behavioral Medicine, Inc.". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 74 completed trials in Center for Psychiatry and Behavioral Medicine, Inc., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Center for Psychiatry and Behavioral Medicine, Inc., 2 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 49 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 11 trials, and there were also 7 trials that are defined as “Not Applicable".